Pharmaceutical manufacturer IDT Australia is to scale up manufacture of cannabis products following news that its customer, Cann Group has secured new export deals with customers in European Union countries.
Cann has won two new export contracts which will see its medicinal cannabis range sold in the United Kingdom, Germany and other EU markets.
IDT develops and scales up pharmaceuticals for manufacturing, and manufactures cannabis formulated oil and dried flower products at its facility at Boronia in eastern Melbourne (pictured).
IDT CEO David Sparling said: “Expanded export channels allow us to scale up our manufacturing and supply operations even further.
“The parties can leverage off IDT’s experience exporting cGMP pharmaceutical products to Europe and our dealings with European regulators.”
IDT’s facilities are cGMP compliant and regularly audited by the US Food and Drug Administration and Australia’s Therapeutic Goods Administration.
Picture: IDT Australia
Subscribe to our free @AuManufacturing newsletter here.